AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs

Company to sell some medicines at a discount to USs Medicaid health plan in exchange for tariff reliefDonald Trump announced a deal with the British-based drugmaker AstraZeneca for a most-favored-nation drug-pricing model aimed at making prescription medicines more affordable and avoiding the administrations tariff threats.The company will sell some medicines at a discount to the governments Medicaid health plan in exchange for tariff relief, similar to a drug-pricing pact reached last week with...